See more : MFA Financial, Inc. 9.000% Seni (MFAO) Income Statement Analysis – Financial Results
Complete financial analysis of Health and Happiness (H&H) International Holdings Limited (1112.HK) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Health and Happiness (H&H) International Holdings Limited, a leading company in the Packaged Foods industry within the Consumer Defensive sector.
- Heineken Holding N.V. (HEIO.AS) Income Statement Analysis – Financial Results
- TMS Co., Ltd. (4891.T) Income Statement Analysis – Financial Results
- Memphasys Limited (MEM.AX) Income Statement Analysis – Financial Results
- SSC Security Services Corp. (SECUF) Income Statement Analysis – Financial Results
- Virat Crane Industries Limited (VIRATCRA.BO) Income Statement Analysis – Financial Results
Health and Happiness (H&H) International Holdings Limited (1112.HK)
About Health and Happiness (H&H) International Holdings Limited
Health and Happiness (H&H) International Holdings Limited, an investment holding company, manufactures and sells family nutrition and baby care products worldwide. The company's Infant Formulas segment produces infant formulas for children under seven years old and milk formulas for expectant and nursing mothers. Its Probiotic Supplements segment offers probiotic supplements in the form of sachets, capsules, and tablets for infants, children, and expectant mothers. The company's Adult Nutrition and Care Products segment produces vitamins, health supplements, and skincare and sports nutrition products for adults. Its Other Pediatric Products segment produces dried baby food and nutrition supplements, and baby care products. The company's Pet Nutrition and Care products segment produces food, health supplements, and bone broth products for pets. It is also involved in the research, development, and processing of meat, fruit, and vegetable powder and candy; research, development, manufacture, and sale of special nutritional foods; marketing and distribution of organic baby foods; and wholesale, retail, import, and export of nutritional food and personal care products for infants. In addition, the company engages in the trading and sale of vitamins, health supplements, probiotic skin care, and sports nutrition products for adults; and provision of online sales, software, and information technology services, as well as packaging services. It provides its products under the Biostime, Swisse, Aurelia, Zesty Paws, Solid Gold, Dodie, Good Gout, Aurelia London, and CBII brands. The company was formerly known as Biostime International Holdings Limited and changed its name to Health and Happiness (H&H) International Holdings Limited in June 2017. The company was founded in 1999 and is headquartered in Quarry Bay, Hong Kong. Health and Happiness (H&H) International Holdings Limited is a subsidiary of Biostime Pharmaceuticals (China) Limited.
Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 13.93B | 12.78B | 11.55B | 11.19B | 10.93B | 10.13B | 8.10B | 6.51B | 4.82B | 4.73B | 4.56B | 3.38B | 2.19B | 1.23B | 558.97M |
Cost of Revenue | 5.45B | 5.07B | 4.30B | 4.01B | 3.70B | 3.39B | 2.83B | 2.45B | 1.83B | 1.80B | 1.59B | 1.15B | 732.91M | 356.39M | 163.02M |
Gross Profit | 8.47B | 7.70B | 7.25B | 7.19B | 7.23B | 6.74B | 5.27B | 4.06B | 2.98B | 2.93B | 2.98B | 2.23B | 1.46B | 877.17M | 395.95M |
Gross Profit Ratio | 60.84% | 60.30% | 62.76% | 64.20% | 66.16% | 66.52% | 65.04% | 62.39% | 61.94% | 61.86% | 65.23% | 65.91% | 66.52% | 71.11% | 70.84% |
Research & Development | 206.08M | 158.19M | 143.96M | 138.98M | 163.70M | 151.18M | 98.63M | 77.25M | 83.98M | 49.72M | 43.73M | 0.00 | 0.00 | 0.00 | 0.00 |
General & Administrative | 834.75M | 727.68M | 695.72M | 679.06M | 638.02M | 619.58M | 486.02M | 357.19M | 280.14M | 175.27M | 177.31M | 116.87M | 82.04M | 87.64M | 26.46M |
Selling & Marketing | 5.60B | 5.24B | 4.97B | 4.60B | 4.49B | 3.70B | 2.71B | 1.95B | 1.98B | 1.59B | 1.51B | 1.08B | 708.60M | 449.45M | 248.30M |
SG&A | 6.43B | 5.96B | 5.67B | 5.28B | 5.13B | 4.32B | 3.20B | 2.31B | 2.26B | 1.76B | 1.69B | 1.19B | 790.65M | 537.09M | 274.76M |
Other Expenses | 0.00 | -31.40M | -35.08M | -51.08M | -42.15M | -478.02M | -355.87M | -140.71M | -206.29M | -83.18M | -52.00M | -37.63M | -48.43M | 6.02M | 3.04M |
Operating Expenses | 6.64B | 5.93B | 5.63B | 5.23B | 5.09B | 4.30B | 3.18B | 2.30B | 2.24B | 1.75B | 1.69B | 1.19B | 742.22M | 543.11M | 277.80M |
Cost & Expenses | 12.09B | 11.00B | 9.93B | 9.24B | 8.79B | 7.69B | 6.01B | 4.75B | 4.07B | 3.56B | 3.28B | 2.35B | 1.48B | 899.50M | 440.82M |
Interest Income | 30.23M | 20.02M | 11.88M | 18.70M | 20.23M | 24.12M | 38.30M | 53.66M | 118.70M | 113.12M | 87.59M | 55.96M | 17.29M | 0.00 | 0.00 |
Interest Expense | 807.61M | 530.29M | 263.74M | 244.02M | 364.55M | 415.40M | 463.90M | 397.84M | 154.02M | 86.67M | 10.59M | 2.11M | 0.00 | 0.00 | 0.00 |
Depreciation & Amortization | 302.25M | 311.28M | 305.48M | 284.25M | 256.43M | 175.38M | 237.80M | 171.97M | 87.17M | 50.67M | 26.56M | 22.58M | 12.98M | 7.06M | 4.80M |
EBITDA | 2.04B | 1.87B | 1.42B | 2.13B | 2.18B | 2.12B | 2.07B | 1.87B | 745.14M | 1.26B | 1.36B | 1.08B | 726.89M | 341.13M | 122.95M |
EBITDA Ratio | 14.67% | 13.75% | 12.09% | 19.20% | 20.50% | 21.14% | 25.18% | 28.68% | 15.46% | 26.54% | 29.86% | 31.79% | 33.21% | 27.65% | 22.00% |
Operating Income | 1.83B | 1.45B | 1.09B | 1.86B | 1.98B | 1.97B | 1.80B | 1.69B | 657.96M | 1.21B | 1.34B | 1.05B | 713.91M | 334.06M | 118.15M |
Operating Income Ratio | 13.16% | 11.31% | 9.45% | 16.66% | 18.16% | 19.41% | 22.24% | 26.04% | 13.65% | 25.47% | 29.28% | 31.13% | 32.61% | 27.08% | 21.14% |
Total Other Income/Expenses | -898.74M | -414.55M | -240.80M | -260.31M | -370.28M | -438.31M | -431.52M | -300.79M | -155.21M | -86.67M | -123.88M | -2.11M | 0.00 | 0.00 | 0.00 |
Income Before Tax | 933.60M | 1.03B | 850.21M | 1.60B | 1.57B | 1.53B | 1.37B | 1.46B | 503.94M | 1.12B | 1.16B | 1.05B | 713.91M | 334.06M | 118.15M |
Income Before Tax Ratio | 6.70% | 8.07% | 7.36% | 14.33% | 14.33% | 15.08% | 16.91% | 22.39% | 10.46% | 23.64% | 25.48% | 31.06% | 32.61% | 27.08% | 21.14% |
Income Tax Expense | 351.76M | 419.15M | 341.73M | 467.97M | 560.15M | 684.78M | 440.24M | 404.56M | 210.62M | 311.55M | 341.38M | 307.47M | 186.56M | 68.38M | 9.84M |
Net Income | 581.85M | 611.78M | 508.48M | 1.14B | 1.01B | 843.15M | 932.85M | 954.40M | 251.46M | 806.79M | 820.72M | 743.11M | 527.35M | 265.68M | 108.32M |
Net Income Ratio | 4.18% | 4.79% | 4.40% | 10.15% | 9.20% | 8.32% | 11.52% | 14.67% | 5.22% | 17.05% | 17.99% | 21.97% | 24.09% | 21.54% | 19.38% |
EPS | 0.90 | 0.96 | 0.79 | 1.77 | 1.57 | 1.32 | 1.48 | 1.52 | 0.41 | 1.34 | 1.37 | 1.24 | 0.88 | 0.58 | 0.24 |
EPS Diluted | 0.90 | 0.95 | 0.79 | 1.76 | 1.55 | 1.30 | 1.46 | 1.50 | 0.40 | 1.31 | 1.34 | 1.22 | 0.86 | 0.58 | 0.24 |
Weighted Avg Shares Out | 646.49M | 640.03M | 644.77M | 643.88M | 641.10M | 637.65M | 633.67M | 630.35M | 613.93M | 602.33M | 602.29M | 602.29M | 602.23M | 456.16M | 450.00M |
Weighted Avg Shares Out (Dil) | 644.87M | 644.32M | 645.67M | 646.56M | 648.07M | 650.22M | 639.46M | 636.06M | 621.49M | 613.96M | 613.12M | 611.58M | 610.54M | 457.42M | 450.00M |
Source: https://incomestatements.info
Category: Stock Reports